+/-mice, respectively. Independent of sex, however, differentially expressed genes cluster in common functional pathways associated with psychiatric disorders, including mitochondrial dysfunction and oxidative phosphorylation as well as G-protein coupled-, and nuclear receptor mediated signaling. Accordingly, we provide in vitro evidence that BRD1
3

Abstract:
The schizophrenia and bipolar disorder associated gene, BRD1, encodes a scaffold protein that in complex with epigenetic modifiers regulate gene sets enriched for psychiatric disorder risk. Preclinical evidence from male Brd1 +/-mice has previously implicated BRD1 with phenotypes of translational relevance to schizophrenia. Here we describe the phenotype of female Brd1 +/-mice and report attenuated dendritic architecture and monoaminergic dysregulation accompanied by sex-specific changes in affective behaviors. In accordance, global gene expression profiling reveals regional dysregulation of gene sets enriched with major depressive disorder and schizophrenia risk in female and male
Brd1
+/-mice, respectively. Independent of sex, however, differentially expressed genes cluster in common functional pathways associated with psychiatric disorders, including mitochondrial dysfunction and oxidative phosphorylation as well as G-protein coupled-, and nuclear receptor mediated signaling. Accordingly, we provide in vitro evidence that BRD1
modulates the transcriptional drive of a subset of nuclear receptors (e.g. the vitamin D and glucocorticoid receptors). Moreover, we demonstrate enrichment of psychiatric disorder risk in the target genes of nuclear receptors, sex-biased expression of several nuclear receptor genes in the adult brain of Brd1 +/-mice, and that sex-biased genes in general are enriched with nuclear receptor genes particularly at the earliest developmental stage of the human brain. Overall, our data suggests that the spatio-temporal interaction between BRD1 and subsets of nuclear receptors in the brain is sex-biased and that hampered BRD1 mediated regulation of target genes governed by certain nuclear receptors may significantly contribute to sex differences in psychopathology.
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Introduction:
Psychiatric disorders are complex multifactorial illnesses characterized by shared genetic risk 1 , overlap in clinical profiles and documented sex differences in their prevalence, symptomatology, and course [2] [3] [4] [5] [6] . Epigenetic processes, such as acetylation of histone lysine residues, are linked with brain development as well as lifelong neural plasticity 7 and have been implicated with the pathophysiology of both psychotic and affective disorders 8 . Bromodomain containing-1 (BRD1) has been identified in complexes involved with histone acetylation and chromatin remodeling 9,10 and interacts at genomic sites enriched with genes implicated in neurodevelopmental processes 10 . BRD1 is widely expressed in human brain 11 , differentially regulated in limbic and neocortical tissues upon exposure to external stressors in rats 12, 13 , and involved in the epigenetic regulation of embryonic development, survival, and differentiation of embryonic stem cells 9, 14, 15 . Supporting a role for BRD1 in mental health, BRD1 has repeatedly been associated with schizophrenia and bipolar disorder in large genetic studies [16] [17] [18] [19] [20] , including gene-wise significant association in the currently largest schizophrenia GWAS mega-analysis 21 and genome-wide significance in the Psychiatric Genomics Consortium (PGC1) schizophrenia sample using an Empirical
Bayes statistical approach 22 . Furthermore, a schizophrenia case with a disruptive nonsense mutation in BRD1, which is generally highly intolerant to loss of function mutations 23 , has been reported 24 . We have recently shown that male mice with reduced expression of Brd1 (Brd1 +/-mice) recapitulate features relating to schizophrenia symptomatology 25, 26 (Table 1) .
In the present study we assess the impact of reduced Brd1 expression on sex differences in the behavioral, neurochemical, and neurostructural domains in mice. Through global gene expression profiling of selected brain structures and integrative analyses of human datasets, we provide evidence linking functional pathways and molecular mechanisms to sex differences in neuropsychiatric pathology.
9 psychostimulatory drug, phencyclidine (PCP) 25 . Suggestive of behavioral despair, female Brd1 +/-mice were significantly more immobile in TST ( Figure 1G , p=0.007) and in FST ( Figure 1H , p=0.002) compared to WT mice, whereas this was not evident in male Brd1 +/-mice ( Figure 1I and Figure 1J ). Sucrose preference was similarly significantly reduced in female Brd1 +/-mice compared to WT mice ( Figure 1K , p=0.001).
Cognitive behaviors: Like reported in male Brd1
+/-mice 25, 26 , female Brd1 +/-mice froze significantly less than WT mice during the conditioning phase of FCS (Figure S3A, p=0.002) and when returning to the same context on the following day ( Figure S3B , p=0.03),
suggesting that female Brd1 +/-mice have context-dependent learning deficits thereby paralleling the cognitive deficits reported in male Brd1 +/-mice 25, 26 . However, unlike their male counterparts 26 , female Brd1 +/-mice did not display cue dependent memory deficits in FCS ( Figure S3C ) and did not differ in working memory errors in 8ARM ( Figure S3D ).
However, they made significantly more entries into the never-baited arms ( Figure S3E , p=0.03), suggesting impaired reference memory, like also reported in male Brd1 +/-mice 26 .
Neurochemistry and psychotropic drug-induced activity: As has previously been reported in male Brd1 +/-mice 25 , female mice displayed unaltered hippocampal serotonin levels ( Figure   2A In line with reduced overall brain tissue volume, aCC pyramidal neurons had significantly shorter dendrites in female Brd1 +/-mice compared to WT mice (Figure 3B, p=0.008) combined with less dendritic branching ( Figure 3C , p=0.01) and less dendritic spine density ( Figure 3D, p<0.001 ). 3-D Sholl analysis counting the dendritic intersections on the concentric spheres with their centres at soma confirmed that these neurons had significantly less dendritic branching ( Figure 3E-F Comparison of expression profiles between male and female Brd1 +/-mice: Utilizing previously published RNA sequencing data from male Brd1 +/-cortex and striatum 25 we compared female and male nominally significant DEGs called using the same DEG analysis pipeline (Table S6 and Table S7 ). The number of DEGs in male Brd1 +/-mice was higher than in female mice (striatum: 2815 vs 1577, and cortex: 2679 vs 725, respectively) ( Figure   S6 ). Nominally significant cortical DEGs overlapped significantly in female and male Brd1 +/-mice ( Figure S6A , p=0.0366), whereas this was not the case for striatal DEGs ( Figure S6B ).
In agreement with the observed regional sex differences in neurochemistry in Brd1 +/-mice mentioned above, fold changes in expression of genes encoding receptors for neurotransmitters, and particularly receptors for monoamines, were markedly different between female and male Brd1 +/-mice in both cortical and striatal tissue ( Figure 4G ). B, and C, RARA, and several types of ESRs) ( Figure 5C ). In addition, we found nominal significant enrichments for psychiatric disorder risk, including major depressive disorder in the target genes of RARA, RARA/RXRG, and LXRA/RXRA ( Figure 5C ). significantly between female and male mice after Benjamini-Hochberg false discovery rate (FDR) correction at 5% ( Figure 5D ). Of the 32 NR encoding genes expressed in aCC, Coup transcription factor α encoding, Nr1d1 (q<0.001), and Pgr (q<0.001) were differentially expressed between female and male WT mice ( Figure 5D ). To examine whether these sexbiased observations are corroborated in data from human brain, we assessed the overlap between NR encoding genes and reported sex-differentially expressed genes across brain regions at 4 developmental stages (prenatal, early childhood, puberty and adulthood) 47 . We found that sex-biased genes are significantly enriched with genes encoding NRs at the earliest developmental stage, with particular enrichment in medial frontal cortex (p=0.006), orbitofrontal cortex (p=0.004) and in the striatum (p=0.01) ( Figure 5E ). Figure 5F ).
Adding to this notion, multiple genes encoding key proteins implicated in neuro-active steroid bio-availability were dysregulated in the brains of female Brd1 +/-mice (see Supplementary 
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